Authors:
Scholten, C
Weinlander, G
Krainer, M
Frischenschlager, O
Zielinski, CC
Citation: C. Scholten et al., Difference in patient's acceptance of early versus late initiation of psychosocial support in breast cancer, SUPP CARE C, 9(6), 2001, pp. 459-464
Authors:
Oehler, L
Berer, A
Keil, F
Weinlander, G
Konig, M
Haas, OA
Lechner, K
Geissler, K
Citation: L. Oehler et al., Generation of dendritic cells from human chronic myelomonocytic leukemia cells in fetal calf serum-free medium, LEUK LYMPH, 38(5-6), 2000, pp. 577
Authors:
Scheithauer, W
Kornek, GV
Raderer, M
Valencak, J
Weinlander, G
Hejna, M
Haider, K
Kwasny, W
Depisch, D
Citation: W. Scheithauer et al., Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer, J CL ONCOL, 17(3), 1999, pp. 902-906
Authors:
Haider, K
Kornek, GV
Kwasny, W
Weinlander, G
Valencak, J
Lang, F
Puribauer, F
Kovats, E
Depisch, D
Scheithauer, W
Citation: K. Haider et al., Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor, BREAST CANC, 55(3), 1999, pp. 203-211
Authors:
Hejna, M
Kornek, GV
Raderer, M
Valencak, J
Weinlander, G
Fiebiger, W
Miholic, J
Scheithauer, W
Citation: M. Hejna et al., 5-Methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: A randomized phase I-II study of two different FU administration schedules, ANN ONCOL, 9(12), 1998, pp. 1309-1314